Atrazine binds to the growth hormone-releasing hormone receptor and affects growth hormone gene expression

Environmental Health Perspectives

Volumn 118, Issue 10, 2010, Pages 1400-1405

  Fakhouri, Walid D ^a,b   Nuñez, Joseph L ^a   Trail, Frances ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

Atrazine; Dexamethasone; GHRH receptor; GHRHR; Growth hormone; Luteinizing hormone; Postnatal pituitary cells; Prolactin; Rat

Indexed keywords

ACTIN; ATRAZINE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR RECEPTOR; HISTONE H3; LUTEINIZING HORMONE; PROLACTIN; RNA; TUBULIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HYPOPHYSIS CELL; IMMUNOFLUORESCENCE TEST; LIGAND BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; RAT; RECEPTOR BINDING;

ANIMALS; ATRAZINE; BASE SEQUENCE; CELLS, CULTURED; DNA PRIMERS; GENE EXPRESSION REGULATION; GROWTH HORMONE; HERBICIDES; LUTEINIZING HORMONE; MALE; PITUITARY GLAND; PROLACTIN; RATS; RECEPTORS, NEUROPEPTIDE; RECEPTORS, PITUITARY HORMONE-REGULATING HORMONE;

ANIMALIA; MAMMALIA; RATTUS;

EID: 77957893695     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.0900738     Document Type: Article

References (53)

1. Arnold AP, Breedlove SM. 1985. Organizational and activational effects of sex steroids on brain and behavior: a reanalysis. Horm Behav 19:469-498.
2. Ashby J, Tinwell H, Stevens J, Pastoor T, Breckenridge CB. 2002. The effects of atrazine on the sexual maturation of female rats. Regul Toxicol Pharmacol 35:468-473.
3. Bloch B, Brazeau P, Ling N, Bohlen P, Esch F, Wehrenberg WB, et al. 1983. Immunohistochemical detection of growth hormone-releasing factor in brain. Nature 301:607-608.
4. Carr JA, Gentles A, Smith EE, Goleman WL, Urquidi LJ, Thuett K, et al. 2003. Response of larval Xenopus laevis to atrazine: assessment of growth, metamorphosis, and gonadal and laryngeal morphology. Environ Toxicol Chem 22:396-405.
5. Casale WL, Hart LP. 1984. Influence of four herbicides on carpogenic germination and apothecium development of Sclerotinia sclerotiorum. Phytopathology 76:980-984.
6. Childs GV, Unabia G, Miller BT. 1994a. Cytochemical detection of GnRH binding sites on rat pituitary cells with LH, FSH, and GH antigens during diestrous upregulation. Endocrinology 134:1943-1951.
7. Childs GV, Unabia G, Miller BT, Collins TJ. 1999. Differential expression of gonadotropin and prolactin antigens by GHRH target cells from male and female rats. J Endocrinol 162:177-187.
8. Childs GV, Unabia G, Rougeau D. 1994b. Cells that express luteinizing hormone (LH) and follicle-stimulating hormone (FSH) β-subunit messenger ribonucleic acids during the estrous cycle: the major contributors contain LHβ, FSHβ, and/or growth hormone. Endocrinology 134:990-997.
9. Cohen LE, Radovick S. 2002. Molecular basis of combined pituitary hormone deficiencies. Endocr Rev 23:431-442.
10. Connor K, Howell J, Chen I, Liu H, Berhane K, Sciarretta C, et al. 1996. Failure of chloro-S-triazine derived compounds to induce estrogenic receptor-mediated responses in vivo and in vitro. Fundam Appl Toxicol 30:93-101.
11. Cooper RL, Stoker TE, Tyrey L, Goldman JM, McElroy WK. 2000. Atrazine disrupts the hypothalamic control of pituitary-ovarian function. Toxicol Sci 53:297-307.
12. Devos S, De Bosscher K, Staels B, Bauer E, Roels F, Berghe WV, et al. 2003. Inhibition of cytokine production by the herbicide atrazine search for nuclear receptor targets. Biochem Pharmacol 65:303-308.
13. European Commission. 2004. Decision Concerning the Non-inclusion of Atrazine in Annex I to the Council Directive 91/414/EEC and the Withdrawal of Authorisations for Plant Protection Products Containing This Active Substance. Official J Eur Union L78:53-55. Available: http://ec.europa.eu/food/plant/protection/evaluation/existactive/oj_atrazine.pdf [accessed 27 August 2010].
14. Gammon DW, Aldous CN, Carr WC, Sanborn JR, Pfeifer KF. 2005. A risk assessment of atrazine use in California: human health and ecological aspects. Pest Manag Sci 61:331-355.
15. Giusi G, Facciolo RM, Canonaco M, Alleva E, Belloni V, Dessi-Fulgheri F, et al. 2006. The endocrine disruptor atrazine accounts for a dimorphic somatostatinergic neuronal expression pattern in mice. Toxicol Sci 89:257-264.
16. Hayes E. 1993. EPA's chemical information database. EPA J 19:48-49.
17. Hayes TB, Case P, Chui S, Chung D, Haeffele C, Haston C, et al. 2006. Pesticide mixtures, endocrine disruption, and amphibian declines: are we underestimating the impact? Environ Health Perspect 114:40-50.
18. Hayes TB, Collins A, Lee M, Mendoza M, Noriega N, Stuart A, et al. 2002a. Hermaphroditic, demasculinized frogs after exposure to the herbicide atrazine at low ecological relevant doses. Proc Natl Acad Sci USA 99:5476-5480.
19. Hayes TB, Haston K, Tsui M, Hoang A, Haeffele C, Vonk A. 2002b. Herbicides: feminization of male frogs in the wild. Nature 491:895-896.
20. Hooghe RJ, Devos S, Hooghe-Peters EL. 2000. Effects of selected herbicides on cytokine production in vitro. Life Sci 66:2519-2525.
21. Huggett J, Dhehada K, Bustin S, Zumla A. 2005. Real-time RT-PCR normalization; strategies and considerations. Genes Immun 6:279-284.
22. Institute of Laboratory Animal Resources. 1996. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press.
23. Iranmanesh A, Bowers CY, Veldhuis JD. 2004. Activation of somatostatin-receptor subtype-2/-5 suppresses the mass, frequency, and irregularity of growth hormone (GH)-releasing peptide-2-stimulated GH secretion in men. J Clin Endocrin Metab 89:4581-4587.
24. Izumi T, Imaizumi C, Ashida E, Ochiai T, Wang PJ, Fukuyama Y. 1985. Suppressive action of ACTH on growth hormone secretion in patients with infantile spasms. Brain Dev 7:636-639.
25. Kniewald J, Jakominic M, Tomljenovic A, Simic B, Romac P, Vranesic D, et al. 2000. Disorders of male rat reproductive tract under the influence of atrazine. J Appl Toxicol 20:61-68.
26. Koskinen WC, Clay SA. 1997. Factors affecting atrazine fate in north central US soils. Rev Environ Contam Toxicol 151:117-165.
27. McMullin TS, Andersen ME, Nagahara A, Lund TD, Pak T, Handa RJ, et al. 2004. Evidence that atrazine and diaminochlorotirazine inhibit the estrogen/progesterone induced surge of luteinizing hormone in female Sprague-Dawley rats without changing estrogen reception action. Toxicol Sci 79:278-286.
28. Mills PK. 1998. Correlation analysis of pesticides use data and cancer incidence rates in California counties. Arch Environ Health 53:410-413.
29. Missale C, Boroni F, Sigala S, Burrani A, Fabris M, Leon A, et al. 1996. Nerve growth factor in the pituitary: localization in mammotroph cells and cosecretion with prolactin by a dopamine-regulated mechanism. Proc Natl Acad Sci USA 93:4240-4245.
30. Mogi C, God H, Mogi K, Takaki A, Yokoyama K, Tomida M, et al. 2005. Multistep differentiation of GH-producing cells from their immature cells. J Endocrinol 184:41-50.
31. Montero M, Yon L, Kikuyama S, Dufour S, Vaudry H. 2000. Molecular evolution of the growth hormone-releasing hormone/pituitary adenylate cyclase-activating polypeptide gene family. Functional implication in the regulation of growth hormone secretion. J Mol Endocrinol 25:157-168.
32. National Center for Biotechnology Information. 2010. GenBank Overview. Available: http://www.ncbi.nlm.nih.gov/genbank/ [accessed 26 August 2010].
33. O'Connor JC, Plowchalk DR, Van Pelt CS, Davis LG, Cook JC. 2000. Role of prolactin in chloro-S-triazine rat mammary tumorigenesis. Drug Chem Toxicol 23:575-601.
34. Ohyama T, Sato M, Ohye H, Murao K, Nimi M, Takahara J. 1998. Effects of adrenalectomy and glucocorticoid receptor antagonist, RU38486, on pituitary growth hormone-releasing hormone receptor gene expression in rats. Peptides 19:1063-1067.
35. Rekasi Z, Varga JL, Schally AV, Halmos G, Groot K, Czompoly T. 2000. Antagonistic actions of analogs related to growth hormone-releasing hormone (GHRH) on receptors for GHRH and vasoactive intestinal peptide on rat pituitary and pineal cells in vitro. Proc Natl Acad Sci USA 97:1218-1223.
36. Sagolio P, Trijasse S. 1998. Behavioral responses to atrazine and diuron in goldfish. Arch Environ Contam Toxicol 35:484-491.
37. Sagrillo CA, Elmanoff M. 1998. Effects of prolactin on expression of the mRNAs encoding the immediate early genes zif/268 (NGF1-A), nur/77 (NGF1-B), c-fos and c-jun in the hypothalamus. Mol Brain Res 61:62-68.
38. Shafer T, Ward TR, Meacham CA, Cooper RL. 1999. Effects of the chlorotriazine herbicide, cyanazine, on GABAA receptor in cortical tissue from rat brain. Toxicology 142:57-68.
39. Spiess J, Rivier J, Vale W. 1983. Characterization of rat hypothalamic growth hormone-releasing factor. Nature 303:532-535.
40. Stoker TE, Cooper RL. 2007. Distribution of 14C-atrazine following an acute lactational exposure in the Wistar rat. Reprod Toxicol 23:607-610.
41. Stoker TE, Guidici DL, Laws SC, Cooper RL. 2002. The effects of atrazine metabolites on puberty and thyroid function in the male Wistar rat. Toxicol Sci 67:198-206.
42. Stoker TE, Robinette CL, Cooper RL. 1999. Maternal exposure to atrazine during lactation suppresses sucking-induced prolactin release and results in prostatitis in the adult offspring. Toxicol Sci 52:68-79.
43. Tamaki M, Sato M, Matsubara S, Wada Y, Takahara J. 1996. Dexamethasone increases growth hormone (GH)-releasing hormone (GRH) receptor mRNA levels in cultured rat anterior pituitary cells. J Neuroendocrinol 8:475-480.
44. Tennant MK, Hill DS, Eldridge JC, Wetzel LT, Breckenridge CB, Stevens JT. 1994. Chloro-S-triazine antagonism of estrogen action: limited interaction with estrogen receptor binding. J Toxicol Environ Health 43:197-211.
45. Thorner MO, Spiess J, Mary LV, Rogol AD, Kaiser DL, Webster JD, et al. 1983. Human pancreatic growth-hormone-releasing factor selectively stimulates growth-hormone secretion in man. Lancet 321:24-28.
46. Trentacoste SV, Friedmann AS, Youker RT, Breckenridge CB, Zirkin BR. 2001. Atrazine effects on testosterone levels and androgen-dependent reproductive organs in peripubertal male rats. J Androl 22:142-148.
47. U.S. Environmental Protection Agency. 2003. Notice of Revised Draft Ambient Water Quality Criteria Document for Atrazine and Request for Scientific Views. EPA Fact Sheet. Available: http://www.epa.gov/waterscience/criteria/atrazine/atrazinefacts.html [accessed 26 August 2010].
48. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. 2002. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:1-12.
49. Varga JL, Schally AV, Csernus VJ, Zarandi M, Halmos G, Groot K, et al. 1999. Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities. Proc Natl Acad Sci USA 96:692-697.
50. Velicelebi G, Patthi S, Kaiser ET. 1986. Design and biological activity of analogs of growth hormone releasing factor with potential amphiphilic helical carboxyl termini. Proc Natl Acad Sci USA 83:5397-5399.
51. Wetzel LT, Luempert LG, Breckendrige CB, Tisdel MO, Stevens JT, Thakur AK, et al. 1994. Chronic effects of atrazine on estrus and mammary tumor formation in female Sprague-Dawley and Fischer 344 rats. J Toxicol Environ Health 43:169-182.
52. Withgott J. 2002. Ubiquitous herbicide emasculates frogs. Science 296:447-448.
53. Xu Y, Berelowitz M, Bruno J. 1995. Dexamethasone regulates somatostatin receptor subtype messenger ribonucleic acid expression in rat pituitary GH4C1 cells. Endocrinology 136:5070-5082.